Panacea Biotec hits 5 per cent upper circuit on fruitful dengue immunization preliminary
The share cost of the worldwide generic, speciality pharmaceutical & vaccine producer, Panacea Biotec, hits 5 per cent upper circuit…
Daily Dose of Financial News